Barbara Klink

6.3k total citations · 1 hit paper
73 papers, 2.5k citations indexed

About

Barbara Klink is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Barbara Klink has authored 73 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 23 papers in Cancer Research and 22 papers in Genetics. Recurrent topics in Barbara Klink's work include Glioma Diagnosis and Treatment (21 papers), Cancer Genomics and Diagnostics (13 papers) and Genomic variations and chromosomal abnormalities (9 papers). Barbara Klink is often cited by papers focused on Glioma Diagnosis and Treatment (21 papers), Cancer Genomics and Diagnostics (13 papers) and Genomic variations and chromosomal abnormalities (9 papers). Barbara Klink collaborates with scholars based in Germany, Luxembourg and Norway. Barbara Klink's co-authors include Gabriele Schackert, Evelin Schröck, Dietmar Krex, Michael Seifert, Michael Sabel, Andreas von Deimling, Joachim P. Steinbach, Guido Reifenberger, Michael Weller and Torsten Pietsch and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Barbara Klink

70 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long-term survival with glioblastoma multiforme

2007 676 citations Dietmar Krex, Barbara Klink et al. Brain profile →

Peers

Countries citing papers authored by Barbara Klink

Since Specialization

Citations

This map shows the geographic impact of Barbara Klink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Klink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Klink more than expected).

Fields of papers citing papers by Barbara Klink

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Klink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Klink. The network helps show where Barbara Klink may publish in the future.

Co-authorship network of co-authors of Barbara Klink

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Klink. A scholar is included among the top collaborators of Barbara Klink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Klink. Barbara Klink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A series of reviews in familial cancer: genetic cancer risk in context variants of uncertain significance in MMR genes: which procedures should be followed? 2025 ·Familial Cancer ·Morghan C. Lucas, T. Keßler, (unknown), Verena Steinke‐Lange, Barbara Klink, Andreas Laner, Elke Holinski‐Feder	1
2	Digital PCR cluster predictor: a universal R-package and shiny app for the automated analysis of multiplex digital PCR data 2023 ·Bioinformatics ·(unknown), Christophe M. Olinger, Barbara Klink, Michel Mittelbronn, Daniel Stieber	5
3	Molecular Characterization of Astrocytoma Progression Towards Secondary Glioblastomas Utilizing Patient-Matched Tumor Pairs 2020 ·Cancers ·Michael Seifert, Gabriele Schackert, Achim Temme, Evelin Schröck, Andreas Deutsch, Barbara Klink	10
4	AN1-type zinc finger protein 3 (ZFAND3) is a transcriptional regulator that drives Glioblastoma invasion 2020 ·Nature Communications ·Anne Schuster, Eliane Klein, Virginie Neirinckx, Arnon Møldrup Knudsen, (unknown), Ann‐Christin Hau, Monika Dieterle, Anaïs Oudin, Petr V. Nazarov, Anna Golebiewska, Arnaud Muller, Daniel Pérez-Hernández, Sophie Rodius, Gunnar Dittmar, Rolf Bjerkvig, Christel Herold‐Mende, Barbara Klink, Bjarne Winther Kristensen, Simone P. Niclou	22
5	Mutant IDH1 Differently Affects Redox State and Metabolism in Glial Cells of Normal and Tumor Origin 2019 ·Cancers ·(unknown), (unknown), Marina Clemente Conde, Mirko Peitzsch, Susan Richter, Ralf Wiedemuth, Khalil Abou‐El‐Ardat, Alexander Krüger, Matthias Meinhardt, Gabriele Schackert, William P. J. Leenders, Christel Herold‐Mende, Simone P. Niclou, Rolf Bjerkvig, Graeme Eisenhofer, Achim Temme, Michael Seifert, Leoni A. Kunz‐Schughart, Evelin Schröck, Barbara Klink	24
6	Network-based analysis of prostate cancer cell lines reveals novel marker gene candidates associated with radioresistance and patient relapse 2019 ·PLoS Computational Biology ·Michael Seifert, Claudia Peitzsch, Ielizaveta Gorodetska, (unknown), Barbara Klink, Anna Dubrovska	32
7	Generation of iPSCs carrying a common LRRK2 risk allele for in vitro modeling of idiopathic Parkinson's disease 2018 ·PLoS ONE ·Lara Marrone, (unknown), David C. Schöndorf, Julia C. Fitzgerald, (unknown), Benjamin Schmid, Peter Reinhardt, Lydia Reinhardt, Michela Deleidi, (unknown), (unknown), Barbara Klink, Michael Glatza, Christian Johannes Gloeckner, Thomas Gasser, Jared Sterneckert	21
8	The contribution of homology arms to nuclease-assisted genome engineering 2017 ·Nucleic Acids Research ·O. K. Baker, (unknown), Jun Fu, Barbara Klink, Andreas Rump, (unknown), Andrea Kranz, Evelin Schröck, Konstantinos Anastassiadis, A. Francis Stewart	27
9	An Epigenetic Reprogramming Strategy to Resensitize Radioresistant Prostate Cancer Cells 2016 ·Cancer Research ·Claudia Peitzsch, Monica Cojoc, (unknown), Ina Kurth, Katrin Mäbert, Franziska Trautmann, Barbara Klink, Evelin Schröck, Manfred P. Wirth, Mechthild Krause, (unknown), Г. Д. Телегеев, (unknown), Marieta Toma, Michael H. Muders, Gustavo Baretton, Fiona M. Frame, Norman J. Maitland, Michaël Baumann, Anna Dubrovska	57
10	OS1.2 Effects of the IDH1R132H mutation on redox-status and metabolism are cell type dependent but independent from D-2-hydroxyglutarate accumulation 2016 ·Neuro-Oncology ·Barbara Klink, (unknown), Matthias Lehmann, Mirko Peitzsch, (unknown), Leoni A. Kunz‐Schughart, Achim Temme, Christel Herold‐Mende, Simone P. Niclou, Evelin Schröck	1
11	An unusual case of Cowden syndrome associated with ganglioneuromatous polyposis 2016 ·Hereditary Cancer in Clinical Practice ·Steffen Pistorius, Barbara Klink, Jessica Pablik, Andreas Rump, Daniela E. Aust, Marlene Garzarolli, Evelin Schröck, Hans K. Schackert	6
12	Ready to clone: CNV detection and breakpoint fine-mapping in breast and ovarian cancer susceptibility genes by high-resolution array CGH 2016 ·Breast Cancer Research and Treatment ·Karl Hackmann, (unknown), (unknown), Anne‐Karin Kahlert, Luisa Mackenroth, Barbara Klink, Nataliya Di Donato, Andreas Tzschach, Karin Kast, Pauline Wimberger, Evelin Schröck, Andreas Rump	12
13	Comprehensive molecular characterization of multifocal glioblastoma proves its monoclonal origin and reveals novel insights into clonal evolution and heterogeneity of glioblastomas 2016 ·Neuro-Oncology ·Khalil Abou‐El‐Ardat, Michael Seifert, Kerstin Becker, (unknown), Matthias Lehmann, Karl Hackmann, Andreas Rump, Gerrit A. Meijer, Beatriz Carvalho, Achim Temme, Gabriele Schackert, Evelin Schröck, Dietmar Krex, Barbara Klink	78
14	Epigenetic Mutation of the Succinate Dehydrogenase C Promoter in a Patient With Two Paragangliomas 2015 ·The Journal of Clinical Endocrinology & Metabolism ·Susan Richter, Barbara Klink, (unknown), Aguirre A. de Cubas, Anastasios Mangelis, Elena Rapizzi, Matthias Meinhardt, (unknown), Massimo Mannelli, Mercedes Robledo, Mario Menschikowski, Graeme Eisenhofer	42
15	Comparative transcriptomics reveals similarities and differences between astrocytoma grades 2015 ·BMC Cancer ·Michael Seifert, (unknown), (unknown), Michel Mittelbronn, Barbara Klink	32
16	Distinct phenotype of PHF6 deletions in females 2014 ·European Journal of Medical Genetics ·Nataliya Di Donato, (unknown), (unknown), C. Le Caignec, Barbara Klink, Cornelia Kraus, Evelin Schröck, Karl Hackmann	15
17	Interstitial deletion 1p36.32 in two brothers with a distinct phenotype – Overgrowth, macrocephaly and nearly normal intellectual function 2014 ·European Journal of Medical Genetics ·Nataliya Di Donato, Barbara Klink, Gabriele Hahn, Evelin Schröck, Karl Hackmann	3
18	Side population in human glioblastoma is non-tumorigenic and characterizes brain endothelial cells 2013 ·Brain ·Anna Golebiewska, Sébastien Bougnaud, Daniel Stieber, Nicolaas H. C. Brons, Laurent Vallar, Frank Hertel, Barbara Klink, Evelin Schröck, Rolf Bjerkvig, Simone P. Niclou	69
19	Partial deletion of GLRB and GRIA2 in a patient with intellectual disability 2012 ·European Journal of Human Genetics ·Karl Hackmann, (unknown), (unknown), Maja von der Hagen, Barbara Klink, Evelin Schröck, Andreas Rump, Nataliya Di Donato	19
20	The prognostic value of IDH mutations and MGMT promoter status in secondary high-grade gliomas 2012 ·Journal of Neuro-Oncology ·Tareq A. Juratli, Matthias Kirsch, Kathrin Geiger, Barbara Klink, Elke Leipnitz, (unknown), Silke Soucek, (unknown), (unknown), Dietmar Krex	64

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact